No abstract available
MeSH terms
-
Adalimumab*
-
Antibodies, Monoclonal
-
Antirheumatic Agents
-
Arthritis, Rheumatoid
-
Cost-Benefit Analysis*
-
Etanercept
-
Humans
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha
Substances
-
Antibodies, Monoclonal
-
Antirheumatic Agents
-
Tumor Necrosis Factor-alpha
-
Adalimumab
-
Etanercept